
Planning for Pharma LOE? The Digital Point-of-Care Makes a Difference
Loss of exclusivity (LOE) is a milestone every novel pharmaceutical product reaches. In anticipation of generic competition and the resulting loss of market share/value,...
Loss of exclusivity (LOE) is a milestone every novel pharmaceutical product reaches. In anticipation of generic competition and the resulting loss of market share/value,...
OptimizeRx is known for our ability to deliver life science brand messages and resources directly in the clinical workflow. As a result, we’re consistently asked by our...
Omnichannel marketing and artificial intelligence (AI) have made targeting clinical audiences easier and more precise. And yet, in the life sciences, we still tend to engage...
Terms like omnichannel, artificial intelligence (AI), data-driven, and real time are defining the conversation around HCP marketing – and for good reason. Today’s savviest...
Pharma and MedTech companies continue to spend billions marketing drugs and devices to physicians. In fact, according to Forbes, pharma spent nearly $4 billion on advertising...
OptimizeRx has released its second Environment, Social and Governance (ESG) report. The report details the Company’s efforts to align with, and show progress against, the 21...
Diabetes continues to plague the healthcare industry, maintaining its status as one of the top public health issues in terms of clinical outcomes and cost. The American...
The growing use of real-world data and AI-driven tools has...